BTIG Starts Kymera Therapeutics (KYMR) at Buy

December 10, 2024 7:21 AM EST Send to a Friend
BTIG analyst Jeet Mukherjee initiates coverage on Kymera Therapeutics (NASDAQ: KYMR) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login